Clearpoint Neuro Price To Book vs. Net Income
| CLPT Stock | USD 14.55 0.21 1.42% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.74 | 0.7 |
|
|
For Clearpoint Neuro profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Clearpoint Neuro to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Clearpoint Neuro utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Clearpoint Neuro's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Clearpoint Neuro over time as well as its relative position and ranking within its peers.
Clearpoint | Build AI portfolio with Clearpoint Stock |
Clearpoint Neuro's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Clearpoint Neuro Revenue Breakdown by Earning Segment
By analyzing Clearpoint Neuro's earnings estimates, investors can diagnose different trends across Clearpoint Neuro's analyst sentiment over time as well as compare current estimates against different timeframes.
Is there potential for Health Care Equipment & Supplies market expansion? Will Clearpoint introduce new products? Factors like these will boost the valuation of Clearpoint Neuro. Projected growth potential of Clearpoint fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Clearpoint Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 0.091 | Return On Assets | Return On Equity |
The market value of Clearpoint Neuro is measured differently than its book value, which is the value of Clearpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Clearpoint Neuro's value that differs from its market value or its book value, called intrinsic value, which is Clearpoint Neuro's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Clearpoint Neuro's market value can be influenced by many factors that don't directly affect Clearpoint Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Clearpoint Neuro's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clearpoint Neuro should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Clearpoint Neuro's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Clearpoint Neuro Net Income vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Clearpoint Neuro's current stock value. Our valuation model uses many indicators to compare Clearpoint Neuro value to that of its competitors to determine the firm's financial worth. Clearpoint Neuro is number one stock in price to book category among its peers. It is rated fourth in net income category among its peers . At this time, Clearpoint Neuro's Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearpoint Neuro by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Clearpoint Net Income vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Clearpoint Neuro |
| = | 27.68 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Clearpoint Neuro |
| = | (18.91 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Clearpoint Net Income Comparison
Clearpoint Neuro is currently under evaluation in net income category among its peers.
Clearpoint Neuro Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Clearpoint Neuro, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Clearpoint Neuro will eventually generate negative long term returns. The profitability progress is the general direction of Clearpoint Neuro's change in net profit over the period of time. It can combine multiple indicators of Clearpoint Neuro, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -17.8 M | -16.9 M | |
| Income Before Tax | -17 M | -16.2 M | |
| Total Other Income Expense Net | 956.8 K | 1 M | |
| Net Loss | -17 M | -16.2 M | |
| Income Tax Expense | -17 M | -16.2 M | |
| Interest Income | 1 M | 672.6 K | |
| Net Loss | -14.8 M | -14.1 M | |
| Net Interest Income | 1 M | 1.1 M | |
| Net Loss | -17 M | -17.9 M | |
| Non Operating Income Net Other | -19.8 K | -18.8 K | |
| Change To Netincome | 4.6 M | 4.8 M | |
| Net Loss | (0.63) | (0.66) | |
| Income Quality | 0.54 | 0.99 |
Clearpoint Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Clearpoint Neuro. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Clearpoint Neuro position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Clearpoint Neuro's important profitability drivers and their relationship over time.
Clearpoint Neuro Earnings Estimation Breakdown
The calculation of Clearpoint Neuro's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Clearpoint Neuro is estimated to be -0.20125 with the future projection ranging from a low of -0.215 to a high of -0.1875. Please be aware that this consensus of annual earnings estimates for Clearpoint Neuro is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.21 Lowest | Expected EPS | -0.19 Highest |
Clearpoint Neuro Earnings Projection Consensus
Suppose the current estimates of Clearpoint Neuro's value are higher than the current market price of the Clearpoint Neuro stock. In this case, investors may conclude that Clearpoint Neuro is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Clearpoint Neuro's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 2 | 73.42% | 0.0 | -0.20125 | -0.83 |
Clearpoint Neuro Earnings History
Earnings estimate consensus by Clearpoint Neuro analysts from Wall Street is used by the market to judge Clearpoint Neuro's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Clearpoint Neuro's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Clearpoint Neuro Quarterly Gross Profit |
|
Clearpoint Neuro Earnings per Share Projection vs Actual
Actual Earning per Share of Clearpoint Neuro refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Clearpoint Neuro predict the company's earnings will be in the future. The higher the earnings per share of Clearpoint Neuro, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Clearpoint Neuro Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Clearpoint Neuro, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Clearpoint Neuro should always be considered in relation to other companies to make a more educated investment decision.Clearpoint Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Clearpoint Neuro's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-11-06 | 2025-09-30 | -0.18 | -0.21 | -0.03 | 16 | ||
2025-08-12 | 2025-06-30 | -0.2 | -0.21 | -0.01 | 5 | ||
2025-05-05 | 2025-03-31 | -0.16 | -0.22 | -0.06 | 37 | ||
2025-02-26 | 2024-12-31 | -0.1737 | -0.2 | -0.0263 | 15 | ||
2024-11-07 | 2024-09-30 | -0.17 | -0.18 | -0.01 | 5 | ||
2024-08-07 | 2024-06-30 | -0.2 | -0.16 | 0.04 | 20 | ||
2024-05-07 | 2024-03-31 | -0.19 | -0.16 | 0.03 | 15 | ||
2024-03-12 | 2023-12-31 | -0.2 | -0.19 | 0.01 | 5 | ||
2023-11-09 | 2023-09-30 | -0.25 | -0.2 | 0.05 | 20 | ||
2023-08-08 | 2023-06-30 | -0.19 | -0.29 | -0.1 | 52 | ||
2023-05-11 | 2023-03-31 | -0.18 | -0.23 | -0.05 | 27 | ||
2023-03-01 | 2022-12-31 | -0.2 | -0.18 | 0.02 | 10 | ||
2022-11-08 | 2022-09-30 | -0.19 | -0.15 | 0.04 | 21 | ||
2022-08-09 | 2022-06-30 | -0.18 | -0.18 | 0.0 | 0 | ||
2022-05-11 | 2022-03-31 | -0.2 | -0.17 | 0.03 | 15 | ||
2022-03-01 | 2021-12-31 | -0.19 | -0.2 | -0.01 | 5 | ||
2021-11-09 | 2021-09-30 | -0.16 | -0.18 | -0.02 | 12 | ||
2021-08-10 | 2021-06-30 | -0.13 | -0.17 | -0.04 | 30 | ||
2021-05-11 | 2021-03-31 | -0.14 | -0.13 | 0.01 | 7 | ||
2021-03-04 | 2020-12-31 | -0.13 | -0.09 | 0.04 | 30 | ||
2020-11-10 | 2020-09-30 | -0.14 | -0.09 | 0.05 | 35 | ||
2020-08-12 | 2020-06-30 | -0.16 | -0.11 | 0.05 | 31 | ||
2020-05-12 | 2020-03-31 | -0.18 | -0.13 | 0.05 | 27 | ||
2020-02-12 | 2019-12-31 | -0.11 | -0.11 | 0.0 | 0 | ||
2019-11-12 | 2019-09-30 | -0.08 | -0.08 | 0.0 | 0 | ||
2019-08-06 | 2019-06-30 | -0.13 | -0.13 | 0.0 | 0 | ||
2016-08-15 | 2016-06-30 | -0.8 | -0.9 | -0.1 | 12 | ||
2016-05-06 | 2016-03-31 | -0.8 | -0.8 | 0.0 | 0 | ||
2016-03-23 | 2015-12-31 | -0.8 | -0.8 | 0.0 | 0 | ||
2015-11-03 | 2015-09-30 | -1.2 | -0.131 | 1.069 | 89 | ||
2015-07-30 | 2015-06-30 | -0.8 | -1.2 | -0.4 | 50 | ||
2015-04-30 | 2015-03-31 | -1.2 | -1.6 | -0.4 | 33 | ||
2015-03-05 | 2014-12-31 | -1.2 | -1.2 | 0.0 | 0 | ||
2014-11-13 | 2014-09-30 | -1.2 | -2.4 | -1.2 | 100 | ||
2014-08-07 | 2014-06-30 | -1.6 | -1.2 | 0.4 | 25 | ||
2013-11-12 | 2013-09-30 | -1.6 | -2.0 | -0.4 | 25 | ||
2013-08-13 | 2013-06-30 | -1.6 | -0.8 | 0.8 | 50 | ||
2013-05-09 | 2013-03-31 | -0.8 | -0.8 | 0.0 | 0 | ||
2013-03-07 | 2012-12-31 | -0.8 | -0.4 | 0.4 | 50 | ||
2012-11-14 | 2012-09-30 | -1.6 | -0.8 | 0.8 | 50 |
Use Clearpoint Neuro in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clearpoint Neuro position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearpoint Neuro will appreciate offsetting losses from the drop in the long position's value.Clearpoint Neuro Pair Trading
Clearpoint Neuro Pair Trading Analysis
The ability to find closely correlated positions to Clearpoint Neuro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clearpoint Neuro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clearpoint Neuro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clearpoint Neuro to buy it.
The correlation of Clearpoint Neuro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clearpoint Neuro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clearpoint Neuro moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clearpoint Neuro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Clearpoint Neuro position
In addition to having Clearpoint Neuro in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 59 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.